Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/1556-4029.13734 | DOI Listing |
AJR Am J Roentgenol
January 2025
Professor of Radiology, UAB Department of Radiology, JTN 344, 619 19th Street South, Birmingham, AL 35249.
Br Dent J
October 2024
Department of Medicine and Department of Cardiovascular Medicine, Division of Public Health, Infectious Diseases and Occupational Health, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.
J Manag Care Spec Pharm
October 2024
CHOICE Institute, School of Pharmacy, University of Washington, Seattle.
Biologic therapies play a critical role in modern medical practice but also present challenges for payers, patients, and other stakeholders because of their high cost. Biosimilars can mitigate the cost pressures of reference biologic therapy because they are typically priced at least 25% lower, providing a means to administer cutting-edge biologic therapy while also managing cost of care. In fact, the US health care system has saved an estimated $23.
View Article and Find Full Text PDFJAMA Dermatol
July 2024
Wadsworth Center Mycology Laboratory, New York State Department of Health, Albany.
Importance: Trichophyton indotineae is an emerging dermatophyte causing outbreaks of extensive tinea infections often unresponsive to terbinafine. This species has been detected worldwide and in multiple US states, yet detailed US data on infections with T indotineae are sparse and could improve treatment practices and medical understanding of transmission.
Objective: To correlate clinical features of T indotineae infections with in vitro antifungal susceptibility testing results, squalene epoxidase gene sequence variations, and isolate relatedness using whole-genome sequencing.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!